Clinical trial
Lysergic Acid Diethylamide Occupancy of the Serotonin 2A Receptor in the Human Brain
NCT05953038 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lysergic Acid Diethylamide Occupancy of the Serotonin 2A Receptor in the Human Brain
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- November 8, 2023
- Completion date
- December 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
basic science